Hypha’s Q3 2017 newsletter: Off-target activity of drug metabolites

This quarter we look at interesting off-target activity of some drug metabolites, using the metabolism of valsartan to 4-hydroxyvaleryl-valsartan as a case study.

Click here for a pdf of the newsletter.